Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China
· Delayed Price · Currency is CNY 26.20
+0.01 (0.04%)
At close: Apr 18, 2025, 2:57 PM CST
SHE:301089 Revenue
Tuoxin Pharmaceutical Group had revenue of 107.00M CNY in the quarter ending September 30, 2024, with 20.02% growth. This brings the company's revenue in the last twelve months to 415.14M, down -62.53% year-over-year. In the year 2023, Tuoxin Pharmaceutical Group had annual revenue of 835.51M with 6.47% growth.
Revenue (ttm)
415.14M
Revenue Growth
-62.53%
P/S Ratio
8.19
Revenue / Employee
267.83K
Employees
1,550
Market Cap
3.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 835.51M | 50.79M | 6.47% |
| Jan 1, 2023 | 784.72M | 282.24M | 56.17% |
| Jan 1, 2022 | 502.48M | -25.46M | -4.82% |
| Dec 31, 2020 | 527.94M | 141.98M | 36.79% |
| Jan 1, 2020 | 385.96M | -5.05M | -1.29% |
| Jan 1, 2019 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Jan 1, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.62B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |